Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Candida Albicans (C. albicans)
60%
Aurès
55%
Candida Auris
36%
Invasive Candidiasis
33%
Colombia
32%
Candida Species
32%
C.albicans
31%
Antifungal Susceptibility
28%
Antimicrobial Peptides
28%
Antifungal Resistance
28%
Epidemiology
24%
Genetic Diversity
24%
Fluconazole
24%
Cell Viability
24%
Antifungal Activity
24%
Invasive Aspergillosis
24%
Pore-forming Peptide
24%
Murine Model
24%
Vero Cells
24%
Clinical Profile
24%
Epidemiological Profile
24%
Disseminated Candidiasis
24%
Fungal Burden
24%
Therapeutic Applications
24%
Rare Yeast
24%
Bogota, Colombia
24%
Morphological Changes
16%
Multidrug-resistant
16%
Cell Surface
16%
Yeast Cells
16%
Scanning Electron Microscopy (SEM-EDS)
16%
C. Glabrata
16%
Colombian
16%
Resistant Isolate
12%
Synthetic Peptides
12%
Therapeutic Potential
12%
Multidrug-resistant Microorganisms
12%
Peptide Toxicity
12%
Histological Analysis
12%
Emerging Threats
12%
Invasive Fungal Infection
12%
Antifungal Effect
12%
Balb C Mice
12%
At-risk
12%
Kidney
12%
Histopathology
12%
Promising Therapeutics
12%
Resistant Strains
9%
Candida Glabrata
8%
Epidemiological Data
8%
Invasive Infection
8%
Candida Guilliermondii
8%
Clonal Dispersal
8%
Candida Infection
8%
Ribosomal DNA
8%
Candida Tropicalis
8%
Candida Parapsilosis
8%
Healthcare Settings
8%
Clinical Impact
8%
Candida Dubliniensis
8%
Comorbidity Treatment
8%
Overall Mortality
8%
Critically Ill Patients
8%
Antibiotics
8%
Diabetes Mellitus
8%
C. Parapsilosis
8%
C. Tropicalis
8%
No Cytotoxicity
6%
Immunology and Microbiology
Candida
100%
Infectious Disease
76%
Infection
76%
Peptides
72%
Candida Auris
70%
Candida albicans
62%
Antifungal Susceptibility
56%
Epidemiology
53%
Cohort Effect
53%
Antimicrobial Peptides
51%
Antifungal Activity
48%
Genetic Variability
48%
In Vitro
36%
Antifungal Resistance
33%
Cell Viability
28%
Aspergillosis
24%
Morphology
20%
Epidemiological Data
15%
Cell Surface
15%
Yeast Cell
15%
Scanning Electron Microscopy
15%
Mortality Rate
13%
Broth Dilution
13%
Microorganism
12%
Bagg Albino Mouse
12%
Biofilm
11%
Meyerozyma guilliermondii
10%
Candida glabrata
10%
Candida Dubliniensis
10%
Candida parapsilosis
10%
Candida tropicalis
10%
Minimum Inhibitory Concentration
6%
Resistant Strain
6%
Comorbidity
6%
Medicine and Dentistry
Invasive Aspergillosis
28%
Retrospective Study
24%
Pathogen
24%
Evans Syndrome
24%
Mixed Infection
24%
Tuberculosis
24%
Infection
13%
Indigenous Peoples
9%
Immunosuppressive Treatment
9%